Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Tristetraprolin expression by keratinocytes controls local and systemic inflammation
Mathieu Andrianne, Assiya Assabban, Caroline La, Denis Mogilenko, Delphine Staumont Salle, Sébastien Fleury, Gilles Doumont, Gaëtan Van Simaeys, Sergei A. Nedospasov, Perry J. Blackshear, David Dombrowicz, Stanislas Goriely, Laurye Van Maele
Mathieu Andrianne, Assiya Assabban, Caroline La, Denis Mogilenko, Delphine Staumont Salle, Sébastien Fleury, Gilles Doumont, Gaëtan Van Simaeys, Sergei A. Nedospasov, Perry J. Blackshear, David Dombrowicz, Stanislas Goriely, Laurye Van Maele
View: Text | PDF
Research Article Dermatology Inflammation

Tristetraprolin expression by keratinocytes controls local and systemic inflammation

  • Text
  • PDF
Abstract

Tristetraprolin (TTP, encoded by the Zfp36 gene) regulates the mRNA stability of several important cytokines. Due to the critical role of this RNA-binding protein in the control of inflammation, TTP deficiency leads to the spontaneous development of a complex inflammatory syndrome. So far, this phenotype has been largely attributed to dysregulated production of TNF and IL‑23 by myeloid cells, such as macrophages or DCs. Here, we generated mice with conditional deletion of TTP in keratinocytes (Zfp36fl/flK14-Cre mice, referred to herein as Zfp36ΔEP mice). Unlike DC-restricted (CD11c-Cre) or myeloid cell–restricted (LysM-Cre) TTP ablation, these mice developed exacerbated inflammation in the imiquimod-induced psoriasis model. Furthermore, Zfp36ΔEP mice progressively developed a spontaneous pathology with systemic inflammation, psoriatic-like skin lesions, and dactylitis. Finally, we provide evidence that keratinocyte-derived TNF production drives these different pathological features. In summary, these findings expand current views on the initiation of psoriasis and related arthritis by revealing the keratinocyte-intrinsic role of TTP.

Authors

Mathieu Andrianne, Assiya Assabban, Caroline La, Denis Mogilenko, Delphine Staumont Salle, Sébastien Fleury, Gilles Doumont, Gaëtan Van Simaeys, Sergei A. Nedospasov, Perry J. Blackshear, David Dombrowicz, Stanislas Goriely, Laurye Van Maele

×

Figure 3

Zfp36 deficiency in keratinocytes results in an increase of multiple transcripts encoding proinflammatory cytokines and chemokines.

Options: View larger image (or click on image) Download as PowerPoint

Zfp36 deficiency in keratinocytes results in an increase of multiple tr...
Zfp36ΔEP mice and their littermate controls (Zfp36fl/fl) (n = 5) were topically treated over 5 consecutive days with imiquimod. Skin samples were collected 4 hours after the last application for transcriptomic analysis. (A) Volcano plot showing log2 fold changes versus log10 P values. As shown from the top of A to the bottom, 1,828 transcripts were significantly upregulated (red) and 1,377 transcripts were significantly downregulated (blue) among all transcripts (gray) in skin from imiquimod-treated Zfp36fl/fl mice compared with mock-treated Zfp36fl/fl mice. Distribution of the 1,828 transcripts (red, the positive imiquimod signature) among all transcripts (gray) in skin from Zfp36ΔEP mice compared with Zfp36fl/fl mice, both treated by imiquimod, and P values for differential expression (upregulation or downregulation) of the gene set (red) are shown. The same analysis was performed for the 1,377 transcripts (blue, the negative imiquimod signature). (B) Heatmap of expression levels of transcripts from the positive and negative imiquimod signatures (as shown in A) significantly (q < 0.05) increased or decreased, respectively, in skin from imiquimod-treated Zfp36ΔEP mice compared with imiquimod-treated Zfp36fl/fl mice. (C) Gene set enrichment analysis of 4 of the most significantly (P < 0.001) enriched KEGG pathways in skin from imiquimod-treated Zfp36ΔEP mice compared with Zfp36fl/fl mice. (D) Enrichment score distribution for the KEGG cytokine-cytokine receptor interaction pathway. (P < 0.001, permutation test) (E) Heatmap of expression levels of genes from the core enrichment of the KEGG cytokine-cytokine receptor interaction pathway. Each column corresponds to a separate mouse.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts